{
  "spec_version": "3",
  "endpoint": "decisions",
  "stock_code": "3549",
  "company_name": "クスリのアオキホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/3549/",
  "api_url": "/api/3549/decisions.json",
  "updated": "2026-08-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/3549/",
  "count": 3,
  "description": "Index of this company's management decisions. One decision = one endpoint: follow api_url for the full dossier (background, the decision itself, outcome, quoted primary sources and references).",
  "decisions": [
    {
      "slug": "dispensing-pharmacy-model-2013",
      "url": "/tse/3549/decisions/dispensing-pharmacy-model-2013/",
      "api_url": "/api/3549/decisions/dispensing-pharmacy-model-2013.json",
      "year": 2013,
      "month": 7,
      "type": "transformation",
      "tags": [
        "pf-diversify-related"
      ],
      "title": "全店に調剤を組み込み、「調剤併設率70%」を掲げる",
      "subtitle": "処方箋の発行率が低い北陸で、クスリのアオキはなぜ調剤を店舗モデルの軸に据えたのか",
      "status": "implemented",
      "status_label": "実施"
    },
    {
      "slug": "food-supermarket-ma-pivot-2021",
      "url": "/tse/3549/decisions/food-supermarket-ma-pivot-2021/",
      "api_url": "/api/3549/decisions/food-supermarket-ma-pivot-2021.json",
      "year": 2021,
      "month": 6,
      "type": "acquisition",
      "tags": [
        "ma-rollup",
        "pf-diversify-related"
      ],
      "title": "食品スーパー連続M&Aによる「フード＆ドラッグ」への業態転換",
      "subtitle": "生鮮を自前で築くのは難しい——ドラッグストアの空白地を、青木宏憲はなぜ地場スーパーの連続買収で埋めたのか",
      "status": "implemented",
      "status_label": "実施"
    },
    {
      "slug": "founder-takeover-defense-2026",
      "url": "/tse/3549/decisions/founder-takeover-defense-2026/",
      "api_url": "/api/3549/decisions/founder-takeover-defense-2026.json",
      "year": 2026,
      "month": 1,
      "type": "governance",
      "tags": [
        "gv-family",
        "cp-activist"
      ],
      "title": "創業家主導での買収防衛策導入とイオンとの資本業務提携解消",
      "subtitle": "議決権4割超を握る青木家は、なぜ「毒薬」で単独路線を選んだのか",
      "status": "implemented",
      "status_label": "実施"
    }
  ],
  "by_type": [
    {
      "key": "acquisition",
      "count": 1,
      "url": "/api/3549/decisions/by-type/acquisition.json"
    },
    {
      "key": "governance",
      "count": 1,
      "url": "/api/3549/decisions/by-type/governance.json"
    },
    {
      "key": "transformation",
      "count": 1,
      "url": "/api/3549/decisions/by-type/transformation.json"
    }
  ],
  "by_decade": [
    {
      "key": "2010s",
      "count": 1,
      "url": "/api/3549/decisions/by-decade/2010s.json"
    },
    {
      "key": "2020s",
      "count": 2,
      "url": "/api/3549/decisions/by-decade/2020s.json"
    }
  ]
}